The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Another is to find stocks with relatively affordable price tags per share. Although it's sometimes the case that the most ...

Sustainable health cannot be solved by science, clinical trial representation and access alone. It’s also down to how we live ...

As the sector’s liabilities are high, 0.3 percent increment of the health budget won’t be enough to meet Sustainable ...

The Global Home Healthcare Services Market will witness a CAGR of 9-10% by 2029. The key factors driving the home healthcare ...

Dr. M.S. Reddy has been granted a groundbreaking United States patent (US Patent #12,268,717 B1) on April 8, 2025.

Roche presented promising 96-week data from the Phase II FENopta study, showing that its investigational drug, fenebrutinib, significantly reduce ...

Angelini is paying $50 million upfront for ex-North American rights to radiprodil, with another $520 million in the offing in ...

Eli Lilly and Company today announced that data from studies of orforglipron, insulin efsitora alfa, tirzepatide (Zepbound and Mounjaro), retatrutide, eloralintide and bimagrumab will be presented at ...